Orchestra BioMed Holdings, Inc.
OBIO
$2.60
$0.051.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.36M | -18.76M | -16.16M | -15.43M | -15.98M |
| Total Depreciation and Amortization | 81.00K | 83.00K | 84.00K | 76.00K | 74.00K |
| Total Amortization of Deferred Charges | 46.00K | 46.00K | 31.00K | -- | -- |
| Total Other Non-Cash Items | 3.35M | 3.00M | 3.87M | 2.29M | 2.63M |
| Change in Net Operating Assets | 358.00K | -990.00K | -1.36M | -639.00K | 3.07M |
| Cash from Operations | -15.53M | -16.62M | -13.54M | -13.70M | -10.21M |
| Capital Expenditure | -34.00K | -112.00K | -106.00K | -68.00K | -107.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -602.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.39M | 13.11M | -3.05M | 625.00K | 10.53M |
| Cash from Investing | 16.36M | 13.00M | -3.75M | 557.00K | 10.42M |
| Total Debt Issued | -- | -- | 15.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 91.00K | 51.00K | 15.04M | 171.00K |
| Repurchase of Common Stock | -428.00K | -387.00K | -550.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -554.00K | -- | -- |
| Cash from Financing | -428.00K | -296.00K | 13.95M | 15.04M | 171.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 401.00K | -3.91M | -3.34M | 1.89M | 389.00K |